Live Updated Worldwide News Related To Bitcoin, Ethereum, Crypto, Blockchain, Technology, Economy. Updated Every Minute. Available In All Languages.
Renowned investor Cathie Wood, chief executive of Ark Investment Management, on Monday purchased a heavy dose of biotechnology stocks.
All valuations below are as of Monday’s close.
Ark funds bought 860,480 shares of Ginkgo Bioworks (DNA) , a biotech company, valued at $2.6 million. The stock has lost 65% year to date.
Ark Genomic Revolution ETF (ARKG) – Get ARK Genomic Revolution ETF Report snatched 604,154 shares of Butterfly Network (BFLY) – Get Butterfly Network Inc. Class A Report, an ultrasound device company, valued at $2.2 million. The stock has slid 46% so far this year.
Source: https://www.thestreet.com/investing/cathie-wood-ark-buys-biotech?puc=yahoo&cm_ven=YAHOO&yptr=yahoo